LXRX
NASDAQ · Pharmaceuticals
Lexicon Pharmaceuticals Inc
$1.42
-0.06 (-4.05%)
Open$1.47
Previous Close$1.48
Day High$1.50
Day Low$1.38
52W High$2.68
52W Low$1.10
Volume—
Avg Volume2.14M
Market Cap716.38M
P/E Ratio—
EPS$-0.15
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+1,165.5% upside
Current
$1.42
$1.42
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 69.22M | 68.34M | 62.90M |
| Net Income | -69,973,085 | 19.40M | 18.23M |
| Profit Margin | -101.1% | 28.4% | 29.0% |
| EBITDA | -67,097,479 | 29.54M | 28.34M |
| Free Cash Flow | — | 10.65M | 12.86M |
| Rev Growth | +692.7% | +10.7% | +9.3% |
| Debt/Equity | 0.50 | 0.92 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |